Table of Contents PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast PART 06: Economic evaluation of peripheral vascular diagnostic systems • Five forces analysis PART 07: Market segmentation by product • Peripheral vascular diagnostic systems • Peripheral vascular diagnostic systems accessories PART 08: Market segmentation by application • Diabetes • Critical limb ischemia PART 09: Market segmentation by end-user • ASCs • Hospitals • Physicians' offices PART 10: Geographical segmentation • Peripheral vascular diagnostic systems market in Americas • Peripheral vascular diagnostic systems market in EMEA • Peripheral vascular diagnostic systems market in APAC PART 11: Market drivers • Diabetes epidemic combined with older population • Presence of specialized cardiology and vascular specialists • Acquisition of small specialized hospitals by Tier-1 hospitals PART 12: Impact of drivers PART 13: Market challenges • Heterogeneous reimbursement scenario • Presence of other non-invasive imaging modalities • Limitation of peripheral vascular diagnostic systems PART 14: Impact of drivers and challenges PART 15: Market trends • Preference of diagnosis at homecare settings • Collaborations for advanced technology development and distribution • Emergence of digital cath labs in hospitals PART 16: Vendor landscape • Competitive landscape analysis PART 17: Key vendor analysis • ArjoHuntleigh • Viasonix • OMRON Healthcare • Opto Circuits • Other prominent vendors PART 18: Appendix • List of abbreviations PART 19: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Prevalence of PAD in various geographical regions Exhibit 03: Correlation between PAD, CAD, and CBVD Exhibit 04: Global peripheral vascular diagnostic systems market by products by technology Exhibit 05: Impact assessment of peripheral vascular diagnostic systems 2016-2020 Exhibit 06: Global peripheral vascular diagnostic systems market 2015-2020 ($ millions) Exhibit 07: Market impact of government initiatives on PAD in developed countries Exhibit 08: Hospitalization cost and limb (toe) amputation for PAD treatment Exhibit 09: Five forces analysis Exhibit 10: Market overview: Peripheral vascular diagnostic systems Exhibit 11: Market overview: Peripheral vascular diagnostic systems accessories Exhibit 12: Matrix analysis: Peripheral vascular diagnostic systems market by product Exhibit 13: Market overview of pressure ulcer Exhibit 14: Market overview of diabetic foot ulcer Exhibit 15: Market overview of critical limb ischemia Exhibit 16: Global peripheral vascular diagnostic systems market by end-user in 2015 Exhibit 17: Peripheral vascular diagnostic systems market: ASCs in Americas Exhibit 18: Peripheral vascular diagnostic systems market: ASCs in EMEA Exhibit 19: Peripheral vascular diagnostic systems market: ASCs in APAC Exhibit 20: Coronary angioplasty same-day basis procedure in hospitals and ASCs in Europe 2014 Exhibit 21: Global peripheral vascular diagnostic systems market by geography 2015 and 2020 ($ millions) Exhibit 22: Global peripheral vascular diagnostic systems market by geography 2015-2020 (% share) Exhibit 23: Market overview: Peripheral vascular diagnostic systems market in Americas Exhibit 24: Number of angiography performed in few countries in Americas 2013 Exhibit 25: Peripheral vascular diagnostic systems market in Americas 2015-2020 ($ millions) Exhibit 26: Peripheral vascular diagnostic systems market in Americas: Metrics analysis for various countries Exhibit 27: Key takeaway: Peripheral vascular diagnostic systems market in the US Exhibit 28: PEST analysis: Peripheral vascular diagnostic systems market in the US Exhibit 29: Market overview: Peripheral vascular diagnostic systems market in EMEA Exhibit 30: Hospital admissions of people with diabetes and PAD in EMEA 2008 and 2013 Exhibit 31: Peripheral vascular diagnostic systems market in EMEA 2015-2020 ($ millions) Exhibit 32: Peripheral vascular diagnostic systems market in EMEA: Metrics analysis for various countries Exhibit 33: Key takeaway: Peripheral vascular diagnostic systems market in the UK Exhibit 34: PEST analysis: Peripheral vascular diagnostic systems market in the UK Exhibit 35: Peripheral vascular diagnostic systems market in APAC 2015-2020 ($ millions) Exhibit 36: Key takeaway: Peripheral vascular diagnostic systems market in India Exhibit 37: PEST analysis: Peripheral vascular diagnostic systems market in India Exhibit 38: Percentage of global older population aged 60+ years, 2010-2050 Exhibit 39: Estimated number of vascular specialists in some countries 2014-2015 Exhibit 40: Number of hospitals merged and acquired from 2010 to 2015 in the US Exhibit 41: Impact of drivers Exhibit 42: US: Reimbursement for peripheral vascular diagnosis in different states 2015 Exhibit 43: Impact of drivers and challenges Exhibit 44: Market impact: Hand-held Doppler ultrasound devices Exhibit 45: Collaborations: Development of advanced technologies and its market impact Exhibit 46: Competitive structure analysis of global peripheral vascular diagnostic market 2015 Exhibit 47: Strategies of companies in global peripheral vascular diagnostic systems market Exhibit 48: Competitive analysis of global peripheral vascular diagnostic systems market 2015 Exhibit 49: Market penetration of various peripheral vascular diagnostic systems manufacturers 2015 Exhibit 50: ArjoHuntleigh: Profile summary Exhibit 51: ArjoHuntleigh: Strength analysis Exhibit 52: ArjoHuntleigh: Growth strategy matrix Exhibit 53: ArjoHuntleigh: Opportunity assessment Exhibit 54: Viasonix: Profile summary Exhibit 55: Viasonix: Strength analysis Exhibit 56: Viasonix: Growth strategy matrix Exhibit 57: Viasonix: Opportunity assessment Exhibit 58: OMRON Healthcare: Profile summary Exhibit 59: OMRON Healthcare: Strength analysis Exhibit 60: OMRON Healthcare: Growth strategy matrix Exhibit 61: OMRON Healthcare: Opportunity assessment Exhibit 62: Opto Circuits: Profile summary Exhibit 63: Opto Circuits: Strength analysis Exhibit 64: Opto Circuits: Growth strategy Exhibit 65: Opto Circuits: Opportunity assessment Exhibit 66: Other prominent vendors in global peripheral vascular diagnostic system

ArjoHuntleigh, Viasonix, OMRON Healthcare, Opto Circuits, ACI Medical Management, BioMedix, Dialog Devices, D.E. Hokanson, ELCAT, FUKUDA DENSHI, Koven Technology, LD Technology, MGC Diagnostics, Medizinische Messtechnik, MESI, Perimed, Väsamed, Wallach Surgical Devices.